AtlasVector
Launch AtlasVector →
BMY62.06+0.56 (+0.92%) session● CONNECTING
AtlasVector › Decision Feed › BMY

BMYcited research thesis

BMY — what changed and why it matters

House verdict · BMY · multi-desk debate + self-falsification

No sealed verdict on BMY yet

No debate has been run on BMY; debates rotate through a watchlist. The conviction call below is the signal engine’s output — one input to a debate, not a multi-desk verdict. Sealed debates on other names, each with its falsification check, are available.
Open the Glass Box →
Individual · $99 a monthThe conviction call on BMY — outside the public coverage list

Covered names include the conviction call in the sealed record at no charge. BMY is outside public coverage; running the signal engine on it requires a seat. The panels above do not depend on it.

Start checkout →
0 of 9 figures below re-derived from a sourcewritten 2026-09-25

BMY — what moved and why today

Context (knowledge graph)

AtlasVector tracks 20 related entities for BMY in its knowledge graph. [c1]

What changed

  • Acadia Pharmaceuticals Fell 19% Today. Here’s Where the Stock Could Go in 2026
  • Bristol Myers Squibb (BMY) Adds Restricted Pharmacy Path For New Myeloma Drug
  • Top Stock Reports for Tesla, sell-side note & Coca-Cola

Valuation spine (rich/cheap)

[c5]

Key takeaways
  • Acadia Pharmaceuticals Fell 19% Today. Here’s Where the Stock Could Go in 2026
  • Bristol Myers Squibb (BMY) Adds Restricted Pharmacy Path For New Myeloma Drug
  • Top Stock Reports for Tesla, sell-side note & Coca-Cola
Headlines · BMY AS OF 2026-09-25 14:53Z
  1. 09-20 12:30ZWall Street's Bull Case for Bristol Myers Squibb Is Getting LouderThe Motley Fool
  2. 09-18 15:40ZBMY vs. ARGX: Which Stock Is the Better Value Option?Zacks Investment Research
  3. 09-24 17:00ZGlobal Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsightGlobeNewswire Inc.
  4. 09-23 13:10ZHow to Maximize Your Retirement Portfolio with These Top-Ranked Dividend StocksZacks Investment Research
  5. 09-21 21:00ZOnco360® is a participating specialty pharmacy in the ZENBEXUS™ (iberdomide) limited dispense networkGlobeNewswire Inc.
  6. 09-18 19:17ZCan Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?Zacks Investment Research

Provenance

verdicts, debates and hash-chained audit seals recorded against BMY
Instruments 1
  • BMY2026-09-24
Session bars 5
  • BMY · Thu Sep 24 session barBMY2026-09-24
  • BMY · Wed Sep 23 session barBMY2026-09-23
  • BMY · Tue Sep 22 session barBMY2026-09-22
  • BMY · Mon Sep 21 session barBMY2026-09-21
  • BMY · Fri Sep 18 session barBMY2026-09-18
Screen metrics 1
  • BMY · screen metrics · Thu Sep 24BMY2026-09-24

7 recorded entities · 6 links. synthetic = the row is flagged as built on synthetic inputs; no provenance = the store holds no synthetic flag for the row. Unmarked rows are flagged non-synthetic. Chain seals list sequence number, event key and SHA-256 chain hash. Verify seal opens the verdict's proof panel, where the sealed record is re-hashed in the browser and compared against the seal.

Cited sources · 5

[c1]AtlasVector knowledge graphgraph context for BMY
[c2]NewswireAcadia Pharmaceuticals Fell 19% Today. Here’s Where the Stock Could Go in 2026
[c3]NewswireBristol Myers Squibb (BMY) Adds Restricted Pharmacy Path For New Myeloma Drug
[c4]NewswireTop Stock Reports for Tesla, sell-side note & Coca-Cola
[c5]AtlasVector valuation spineconsensus valuation

The full record is in AtlasVector.

Standing monitors, multi-desk debate, audited paper trading and a persistent research record.

Open AtlasVector →